---All---
  • ---All---
  • Accession
  • Catalog #

TCF7L2 Antibody (monoclonal) (M03)Purified Mouse Monoclonal Antibody (Mab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AT4190a 100 ug 400 ul 7-10 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

TCF7L2 Antibody (monoclonal) (M03) - Product info

ApplicationIF, WB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ9NQB0
Other AccessionNP_110383
ReactivityHuman
IsotypeIgG1 Kappa
Clone Names3D7
Calculated MW67919 Da

TCF7L2 Antibody (monoclonal) (M03) - Additional info

Gene ID 6934
Other Names
TCF4, TCF4transcription factor 7-like 2 (T-cell specific, HMG-box)
Target/Specificity
TCF7L2 (NP_110383, 490 a.a. ~ 597 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Dilution
WB~~1:500~1000
Format
Clear, colorless solution in phosphate buffered saline, pH 7.2 .
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
TCF7L2 Antibody (monoclonal) (M03) is for research use only and not for use in diagnostic or therapeutic procedures.

TCF7L2 Antibody (monoclonal) (M03) - Related products

AP12416a: TCF7L2 Antibody (N-term)

RI15258: TCF7L2 predesign siRNA

AT4190a: TCF7L2 Antibody (monoclonal) (M03)

AT4191a: TCF7L2 Antibody (monoclonal) (M05)

AT4192a: TCF7L2 Antibody (monoclonal) (M06)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes.

REFERENCES

Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion. Heni M, et al. Diabetes, 2010 Aug 29. PMID 20802253.Role of BMI in the Association of the TCF7L2 rs7903146 Variant with Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study. Kucharska-Newton AM, et al. J Obes, 2010. PMID 20798759.Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: common genetic variants in GCK and TCF7L2 are associated with fasting and post-challenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes from the International Association of Diabetes and Pregnancy Study Groups. Freathy RM, et al. Diabetes, 2010 Aug 3. PMID 20682688.The balance of TCF7L2 variants with differential activities in Wnt-signaling is regulated by lithium in a GSK3beta-independent manner. Struewing I, et al. Biochem Biophys Res Commun, 2010 Aug 20. PMID 20654575.Potential role of TCF7L2 gene variants on cardiac sympathetic/parasympathetic activity. Boccardi V, et al. Eur J Hum Genet, 2010 Jul 21. PMID 20648057.